Insider Transactions Reported by 21 Insiders of Cue Biopharma, Inc.

Symbol
CUE on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Cue Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael J. Fox Director $3,036,000 05 Jun 2024
Cameron Gray Director $1,896,255 14 Jun 2022
Anish Suri President And Cso $374,361 05 Jun 2024
Daniel R. Passeri CHIEF EXECUTIVE OFFICER, Director $169,515 21 Mar 2025
Pasha Sarraf Director $97,675 +$99,747 02 Jan 2026
Aaron G.l. Fletcher Director 03 Jan 2023
Patricia Nasshorn Chief Business Officer 16 Feb 2023
Peter A. Kiener Director 02 Jan 2026
Matteo Levisetti Chief Medical Officer 21 Mar 2025
Colin Sandercock Svp, General Counsel 26 Sep 2025
Frank Morich Director 02 Jan 2026
Pamela Garzone Director 02 Jan 2026
Kerri-Ann Millar Chief Financial Officer 21 Mar 2025
Frederick W. Driscoll Director 02 Jan 2025
Tamar D. Howson Director 03 Jan 2023
Jill Marie Broadfoot Director 02 Jan 2026
Lucinda Warren Chief Business Officer 29 Sep 2025
Kenneth Pienta Chief Medical Officer 25 Mar 2022
Patrick Verheyen Director 02 Jan 2026
Usman Azam CHIEF EXECUTIVE OFFICER, Director 29 Sep 2025
Daniel G. Baker Chief Development Officer 29 Sep 2025

Recent Insider Transactions by Companies or Individuals for Cue Biopharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Peter A. Kiener CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Jill Marie Broadfoot CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Pamela Garzone CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Frank Morich CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Patrick Verheyen CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Pasha Sarraf CUE Stock Option (right to buy) Award 24,400 24,400 02 Jan 2026 Direct
Pasha Sarraf CUE Common Stock Purchase $99,747 $0.3080 323,857 323,857 30 Dec 2025 Direct
Colin Sandercock CUE Stock Option (right to buy) Award 70,000 70,000 03 Dec 2025 Direct
Lucinda Warren CUE Stock Option (right to buy) Award 125,000 125,000 29 Sep 2025 Direct
Daniel G. Baker CUE Stock Option (right to buy) Award 50,000 50,000 29 Sep 2025 Direct
Usman Azam CUE Stock Option (right to buy) Award 1,875,000 1,875,000 29 Sep 2025 Direct
Colin Sandercock CUE Stock Option (right to buy) Award 30,000 30,000 26 Sep 2025 Direct
Jill Marie Broadfoot CUE Stock Option (right to buy) Award 48,800 48,800 04 Jun 2025 Direct
Kerri-Ann Millar CUE Stock Option (right to buy) Award 200,000 200,000 21 Mar 2025 Direct
Daniel R. Passeri CUE Stock Option (right to buy) Award 450,000 450,000 21 Mar 2025 Direct
Daniel G. Baker CUE Stock Option (right to buy) Award 100,000 100,000 21 Mar 2025 Direct
Colin Sandercock CUE Stock Option (right to buy) Award 200,000 200,000 21 Mar 2025 Direct
Lucinda Warren CUE Stock Option (right to buy) Award 250,000 250,000 21 Mar 2025 Direct
Matteo Levisetti CUE Stock Option (right to buy) Award 250,000 250,000 21 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.